Full time finance content creator maths and science tutor for 23 years
Tesla investors just got another major catalyst to debate: Cybercab has officially moved from an idea on a presentation slide to an actual vehicle carrying passengers.That sounds extremely bullish.And...
Both tickers resolved — OCBC (O39.SG) and NTT DC REIT (NTDU.SG, USD-quoted on SGX). Now pulling quotes, financials, and news on bothData so far is solid. Now verifying the two announcements' details a...
📊 TA CHECK: TIGR, GRAB, QUBT & CLSK 🐯 TIGR — Best Fit for Your Covered-Call PlanTIGR is currently around $5.07 after a strong move higher.🎯 Technical viewCurrent: ~$5.07Your reference cost: ~$4.98Impo...
Three "defensive" stocks, stress-tested: Hasbro, Royal Caribbean, ManulifeThe following is an informational analysis and does not constitute investment advice or a buy/sell recommendation.Against the ...
S$15,000 Profit in August: Discipline, Covered Calls & China FuturesAugust was a month that reminded me of one of the most important lessons in trading: making money is not always about predicting the...
.🌪️ A Big Week for Technology StocksIf you own technology stocks right now, this is the week that teaches you how the game is played. 📚📈On Tuesday, September 1, Wall Street had one of its worst sessio...
🧠 The Big Idea: “Buy When It’s Quiet, Sell When War News Returns” A popular trading idea is simple: buy energy stocks when geopolitical tensions appear to be cooling, then sell when war headlines retur...
📈 My AVGO prediction: +4% to +8%
I’m leaning bullish for Broadcom’s September 3 close. AI semiconductor demand remains extremely strong, with Q3 revenue expected around $29.4B, while AI chip revenue continues to accelerate.
However, expectations are already high, so I don’t expect a huge Nvidia-style move. My base case is AVGO around $385–$400, assuming guidance is raised and management gives a strong AI outlook. 🚀
My call: +4% to +8% 🎯@Captain's Watch
Anthropic locked in a $35B cloud deal with Nvidia-backed Lambda on Sunday — its fourth mega compute deal this month. Rate-hike odds jumped again too, hitting 64-65% just one trading day after Friday's...
The recent Marvell Technology (MRVL) sell-off is actually a useful lesson for beginners: a company can report excellent growth and still see its stock fall. Marvell reported Q2 FY2027 revenue of $2.73...
🚀 A New Chapter Begins at AppleApple is approaching one of the biggest product changes in its history. John Ternus is set to become Apple’s CEO on September 1, with Tim Cook moving into the role of ex...
The market had been pricing in liquidity, lower rates and a friendly Fed. Then Jackson Hole changed the story. 😳📊 Kevin Warsh’s hawkish tone pushed investors to reconsider the path of interest rates, ...
Heat some correction to buy
No print in this market carries more than $NVIDIA(NVDA.US): a US$5.07 trillion company reporting into its longest losing streak since 2022, with the whole AI stack repriced behind it. In three days th...
🚀 Nvidia Reclaims the AI Narrative — But What Happens to the Rest of the AI Supply Chain?Nvidia has once again reminded investors why it remains at the centre of the artificial-intelligence boom.The l...
Why the Cybercab rollout is a structural revenue story for Tesla — not just another car launch The platform question first. To see what the robotaxi move actually does to Tesla's top line, you have to...
Every headline number checks out — and the erosion is coming from the core business, not one-off noise.The headline was realAlibaba's August 2026 quarter (fiscal Q1 2027) delivered exactly the kind of...
Nice spot like
SG earnings homework, the memory trade's second act, the NVDA countdown, and required reading on SGX's new gold & silver DLCs — the week's sharpest community takes.
A catalyst is an event or piece of news that can change how investors think about a company’s future.Think of it simply:Good news → better expectations → more buyers → potentially higher stock priceTh...
📈 Why Do Stocks Rise on Good News?
A catalyst is news that changes investors’ expectations about a company’s future. Merck and Moderna’s positive Phase 3 melanoma trial is a good example. The treatment met its main goal and reduced the risk of cancer returning or death. This creates potential for regulatory submission, approval and future revenue. Investors may therefore believe the companies are worth more. However, good news does not guarantee a rise because the market may have already priced in the expectations.@Captain's Watch
Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...
.Beginner's Guide: Finding Value in the Magnificent 7Part 1: Ranking the Mag 7 by Valuation — Who's Actually Cheap?The "Magnificent 8" — [stock Apple], [stock Microsoft], [stock Alphabet], [stock Amaz...
🚀 NVIDIA was trading around $219–$220, and I decided to do two things at the same time: I bought a small amount of NVIDIA shares around $218.86, while also selling a cash-secured put with a $205 strik...
